YTE reported $222K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agenus AGEN:US USD 2.95M 120K
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Bristol Myers Squibb BMY:US USD 292M 0
Clovis Oncology CLVS:US USD 145K 1000
Cti Biopharma CTIC:US USD 127K 13K
Eli Lilly And LLY:US USD 594.1M 0
Exelixis EXEL:US USD 323K 1000
Gilead Sciences GILD:US USD 1000K 0
Idera Pharmaceuticals IDRA:US USD 59K 6K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Macrogenics MGNX:US USD 615K 0
Merk MRK:US USD 1.79B 0
Mirati Therapeutics MRTX:US USD 58K 2K
Moderna Inc MRNA:US USD 38.7K 500
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Newlink Genetics NLNK:US USD 83K 0
Novartis NOVN:VX USD 890M 0
Ptc Therapeutics PTCT:US USD 71K 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 185K 1000
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0